GE HealthCare raises 2026 guidance after strong Q3 results
Revenue grew 6.2% year-over-year to $5.5 billion. Adjusted EPS reached $1.34, and free cash flow hit $793 million.
See the latest news and media coverage for GE HealthCare. We track all announcements, press releases, and industry mentions in real time, all in one place.
Healthcare technology and services company
gehealthcare.comLast updated
In short: GE HealthCare reported record Q2 orders, agreed to acquire SOFIE Biosciences, and expanded theranostics imaging.
Revenue grew 6.2% year-over-year to $5.5 billion. Adjusted EPS reached $1.34, and free cash flow hit $793 million.
The company will release financial results on October 28, 2026, at 8:30 a.m. Eastern Time, accompanied by a conference call and live webcast for investors.
The deal establishes GE HealthCare's US radiopharmaceutical footprint. Expected to close in H1 2027 after regulatory approval.
The board declared a $0.04 per share dividend, a 14% increase, payable on November 13, 2026.
GE HealthCare beat Q3 Wall Street estimates on strong imaging and diagnostics sales, prompting the...
Revenue climbed over 7% to $5.5 billion, surpassing analysts' consensus of $5.35 billion. GE HealthCare shares rose over 7% on Wednesday morning following the report...
The deal expands GE HealthCare’s footprint in radiopharmaceuticals, its fastest-growing segment.
GE HealthCare Technologies Inc. ( GEHC) revealed earnings for its third quarter that Increases, from the same period last year The company's bottom line totaled...
Track GE HealthCare and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to GE HealthCare and other trending companies.